Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.43 USD
Change Today -0.0111 / -2.52%
Volume 541.0K
OPXA On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Neil K. Warma

Chief Executive Officer, President and Director, Opexa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 2 different industries.

See Board Relationships
52$1,810,749
As of Fiscal Year 2014

Background*

Mr. Neil K. Warma has been the Chief Executive Officer and President of Opexa Therapeutics, Inc., since June 16, 2008 and serves as its Secretary. Mr. Warma served as an Acting Chief Financial Officer and Principal Accounting Officer of Opexa Therapeutics Inc., since March 2009 until August 15, 2012. He served as the Chief Executive Officer and President of Viron Therapeutics Inc. from 2004 to August 2007. While at Viron, Mr. Warma oversaw the launch of its first Phase ...

Read Full Background

Corporate Headquarters*

2635 Technology Forest Boulevard
The Woodlands, Texas 77381

United States

Phone: 281-272-9331
Fax: 281-872-8585

Board Members Memberships*

Former Chief Executive Officer, President and Director
Director
2008-Present
Chief Executive Officer, President and Director

Education*

Honors Degree
University of Toronto
MBA
Schulich School Of Business At York University

Other Affiliations*

Annual Compensation*

Salary$406,464
Bonus$172,747
Total Annual Compensation$579,211

Stock Options*

Restricted Stock Awards$94,181
Exercisable Options305,774
Unexercisable Options703,693
Total Number of Options1,009,467

Total Compensation*

Total Annual Cash Compensation$579,211
Total Short Term Compensation$579,211
Other Long Term Compensation$94,181
Total Calculated Compensation$1,810,749
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPXA:US $0.43 USD -0.0111

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
--
Weidong Yin Chairman, Chief Executive Officer, President, Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Sinovac Biotech Ltd.
--
Zhilin Li Chairman, Chief Executive Officer, President and Interim Chief Financial Officer
China Pharma Holdings, Inc.
$225.6K
Guoqing Jiang M.D.Chairman, Chief Executive Officer, President, Acting Chief Financial Officer and Chief Accounting Officer
Tianyin Pharmaceutical Co., Inc.
$100.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPEXA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.